Abilify Maintena
Payments companies reported to CMS as associated with Abilify Maintena. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Abilify Maintena, per program year, as reported to CMS.
Who makes it
- Otsuka America Pharmaceutical, INC. $9.2M associated with Abilify Maintena (2023-2025)
- H. Lundbeck A S $400K associated with Abilify Maintena (2023-2025)
- Lundbeck LLC $259K associated with Abilify Maintena (2023-2025)
- Otsuka Pharmaceutical Co., Ltd. $48K associated with Abilify Maintena (2023-2025)
- Otsuka Pharmaceutical Development & Commercialization, INC. $27K associated with Abilify Maintena (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Abilify Maintena
These are the largest totals companies reported as associated with Abilify Maintena. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rebecca Roma | Pittsburgh, PA | Psychiatry | $283,497.52 |
| Rifaat El-Mallakh | Louisville, KY | Psychiatry | $255,310.69 |
| Henry Nasrallah | Cincinnati, OH | Psychiatry | $235,954.10 |
| Todd Broder | St Augustine, FL | Psychiatry | $213,658.39 |
| Suresh Sureddi | Plano, TX | Psychiatry | $209,413.90 |
| Kent Mcdaniel | Glen Allen, VA | Psychiatry | $208,525.97 |
| Tracey Skale | Cincinnati, OH | Psychiatry | $203,568.93 |
| Charles Tuan-Tu Nguyen | Irvine, CA | Psychiatry | $201,423.90 |
| Leslie Citrome | Pomona, NY | Psychiatry | $200,710.42 |
| Ilan Melnick | Coral Gables, FL | Psychiatry | $194,488.04 |
Prescribed Abilify Maintena?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.